Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02733003 · ClinicalTrials.gov registry record · NA

Implementation Research for Vulnerable Women in South Africa

A NA study, sponsored by RTI International.

Completed
Registry status
NA
Development phase
564
Enrollment target

NCT02733003: Completed NA study, sponsored by RTI International.

NCT02733003 is a NA study that has completed, run by RTI International. The registered enrollment target is 564 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02733003, a NA study, has completed, sponsored by RTI International.

COMPLETED
Registry status
NA
Development phase
564 participants
Enrollment target

Study Summary

This study sought to implement the Women's Health CoOp (Cooperative) (WHC) intervention into healthcare, antenatal, and substance treatment clinics in South Africa and translated this evidence-based intervention into real-world settings. Implementation, service, and patient outcomes will be evaluated through an iterative stepped wedge design.

Primary Outcome

Explore perceived appropriateness of implementing the intervention through qualitative focus groups with clinic staff and patients

Interventions

  • BEHAVIORAL Women's Health CoOp (WHC)

Trial Details

FieldValue
Enrollment Target 564 participants
Start Date 2015-09
Est. Completion 2018-12-04
Phase NA
RTI International

45 total trials

What the finished NCT02733003 record still lists

NCT02733003 is an interventional study that assigns participants to a tested intervention. The registered 564 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).

The record links to 0 conditions, and to 1 intervention - of which Women's Health CoOp (WHC) is the first listed.

NCT02733003 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02733003 about?

NCT02733003 is a clinical study titled "Implementation Research for Vulnerable Women in South Africa". This study sought to implement the Women's Health CoOp (Cooperative) (WHC) intervention into healthcare, antenatal, and substance treatment clinics in South Africa and translated this evidence-based intervention into real-world settings. Implementation, service, and patient outcomes will be evaluate...

What is the current status of trial NCT02733003?

This trial is currently completed. It is a NA study. The enrollment target is 564 participants. The study started on 2015-09. Estimated completion is 2018-12-04.

What interventions are being tested in trial NCT02733003?

The interventions under investigation include: Women's Health CoOp (WHC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02733003?

This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02733003's enrollment target sits among peer trials

564 180th of 2000 higher than 1,820 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06146725 · 564 participants

    The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

  • NCT06188520 · 564 participants · Phase 1

    A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors

  • NCT06628453 · 564 participants · NA

    CGM for Management of Type 2 Diabetes in Pregnancy

  • NCT07125326 · 564 participants · NA

    How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02733003, the US trial registry maintained by the National Library of Medicine. NCT02733003 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.